Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Incorporating alternative investments into your long-term portfolio can enhance diversification and improve returns.
27,567 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
JPMorgan faces renewed scrutiny as Scott Bessent challenges its research on insurance for ships transiting the Strait...
Bitcoin trades around $55K as ETFs diverge in approach. This timely analysis explains what bitcoin $55k means for IBI...
Binance adds CFG to three spot markets, sparking a rapid, 63% price spike for Centrifuge. The move highlights how exc...
Micron Technology is set to release quarterly results after the bell, with investors hoping for a blowout fueled by A...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Micron’s stock is dropping amid questions about whether Google's new AI memory efficiency could curb DRAM demand. Her...
BlinkEx unveils a security-first crypto exchange as traders grow wary of outages and freezing assets. The launch aims...
Florida citrus growers face a multi-year test as disease, drought, and storms erode yields and profits. Farmers are a...
GameStop’s bid to acquire eBay is stirring a heated market debate over value and risk. Analysts say the move may be m...
As rates push beyond 6.6%, loan officers saving deals deploy new tactics to preserve contracts, including seller cred...
A Kentucky GOP primary produced a win for a Trump-backed challenger, marking a new chapter in Trump’s hold on the par...